Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.
about
Pelvic mass associated with raised CA 125 for benign condition: a case reportResults from four rounds of ovarian cancer screening in a randomized trialIn 2014, can we do better than CA125 in the early detection of ovarian cancer?Ovarian cancer screening--current status, future directionsOvarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.A note from history: Landmarks in history of cancer, part 7.Progress and challenges in screening for early detection of ovarian cancer.Diagnostic accuracy of DWI in patients with ovarian cancer: A meta-analysis.Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancerPhase II biomarker trial of a multimarker diagnostic for ovarian cancerThe serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumorsEarly detection of ovarian cancerIdentification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.Ectopic expression of N-acetylglucosamine 6-O-sulfotransferase 2 in chemotherapy-resistant ovarian adenocarcinomas.Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.Differences in tumor-associated protein levels among middle-age Flemish women in association with area of residence and exposure to pollutantsA multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.Examining the cost-effectiveness of cancer screening promotion.Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.A patient with tuberculous peritonitis with very high serum CA 125.Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancerCombining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerEarly detection biomarkers for ovarian cancer.The value of ovarian cancer screening.Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.Multiple biomarker panels for early detection of ovarian cancer.Pollutant effects on genotoxic parameters and tumor-associated protein levels in adults: a cross sectional study.Evaluation of Preoperative Serum Levels of CA 125 and Expression of p53 in Ovarian Neoplasms: A Prospective Clinicopathological Study in a Tertiary Care Hospital.CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratomaAssessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic massRecruitment to multicentre trials--lessons from UKCTOCS: descriptive studyOvarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.Correlation of cytohistlogical expression and serum level of ca125 in ovarian neoplasm.Peri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new insights and clinical management.A review of cost-effectiveness studies in ovarian cancer.Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.Changes in cancer worry associated with participation in ovarian cancer screening.
P2860
Q24630815-55607C4C-42B3-4632-BB72-A3642AE81255Q24650747-5310ED31-F941-45CF-8BC7-863402C9E0D7Q26825152-F9A4432C-5B9D-4ECB-BBF1-0BD8348ED3E0Q27004471-C38329D7-35FF-4B6D-8B39-BF365A964799Q30724410-809D9B80-A349-426D-80E8-48FB8DA4E03BQ30740899-2BEADBF7-82A2-465D-9B4D-A62108555AC9Q30931923-84D13D65-1E34-4E80-826F-A858ED29EFADQ31041170-33A0BC32-8B7A-4A22-BC26-16B4E4343A6FQ33672451-38BF4D11-E7EE-49F7-B903-96A2267DB2CCQ33843741-A329DB37-923A-4FF7-9CA0-B7F67E20FEB8Q33868802-D35A9758-E651-4A1E-8189-7C0A4CCB9347Q33996600-E91C5652-1F48-47EB-BF0C-285893D6D84BQ34094731-A18B71E4-9614-417F-B1C4-F6B8C2377AB8Q34244781-64D35775-C854-4685-969B-B1E8F201F95BQ34555511-83A7C995-CF9B-4FE9-8B98-C08AEC2590E3Q34589423-E7621115-1941-4847-92CD-621CE6FD0C28Q34609686-11C990D5-02EA-46BD-B341-762AE7A1453AQ34687376-6FDAC026-52AF-45CD-B8D2-FBFCAA86699AQ35736066-DB82C205-69B4-4B3B-B8E8-E567DEDE2346Q35865876-7B01F42C-CF9B-4B94-BEA5-044C5A57859DQ35934073-646081F1-9668-4B9B-9A75-902267D1F752Q35977188-0AE62580-9BA3-4311-A141-D709B1805A15Q36292714-469BBD22-1D4A-43CB-87DA-B916D7666EFCQ36320253-87FAD773-0E28-4627-82FD-9F12B5022D41Q36520143-2166986D-8BB5-4156-B9F7-CB44A3EDE31BQ36527616-571B035A-7DC8-48EC-A4C2-0E8790CB9A04Q36620469-21BA2909-00BC-4AA0-8309-0B9C3F548B12Q36677487-0B7DC51F-83B0-47F6-B4F3-ED7DEBC0577CQ36742157-625B3872-36BD-4B30-8732-C0EDB2FB8EA7Q36759690-B5147B44-01CE-44E4-A85E-B424A2D0E2E8Q36773181-E905A114-D41C-4771-8272-91637F0B7A1DQ36904090-DB3A28CC-9AE3-48FC-81EF-8DCD59CED3BDQ36973956-14BE9D95-A1FE-4DDE-B57D-C573FC7E20F6Q37621316-D5482DB8-518B-4A5E-91CD-6ABC758F8826Q37695528-10CF0B15-A0AA-4340-8145-2899DD5A28EAQ37730502-0B31B060-F21A-474D-BD64-967D4AAE47C3Q37760524-E68B9B0C-6B21-4E4A-B9B8-2C715351EE3FQ37832934-670EFE80-A3F4-4170-9268-AF39B1F3A1D3Q38988184-EB73CD14-8AB5-4E50-9B0A-CF8F4415A5ABQ39782186-BA85E400-95BF-4757-8EF4-262C45E7604E
P2860
Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Risk of diagnosis of ovarian c ...... n: a prospective cohort study.
@ast
Risk of diagnosis of ovarian c ...... n: a prospective cohort study.
@en
type
label
Risk of diagnosis of ovarian c ...... n: a prospective cohort study.
@ast
Risk of diagnosis of ovarian c ...... n: a prospective cohort study.
@en
prefLabel
Risk of diagnosis of ovarian c ...... n: a prospective cohort study.
@ast
Risk of diagnosis of ovarian c ...... n: a prospective cohort study.
@en
P2093
P2860
P1433
P1476
Risk of diagnosis of ovarian c ...... n: a prospective cohort study.
@en
P2093
Jeyerajah A
Weidemann P
P2860
P304
P356
10.1136/BMJ.313.7069.1355
P407
P577
1996-11-01T00:00:00Z